Monday, October 22, 2018 11:07:10 PM
UNLESS you know or believe that there is much higher ground ahead.
What about AREC? It came public through a reverse merger in early 2018.
It's traded between 5 cents and $8.00. It's been trading over $5 per share since early September and seemingly holding its own above $7 for the last two weeks.
At present, the public float is 98,000 shares... 1.04 shares outstanding. There are more shares when fully diluted, but these belong to management which they received in exchange or debt they were owed... (fully diluted 17.1 million).
What are shares of AREC worth? There's the question that will be answered in the next few weeks and months.
(see next post)
Watch for opportunities with those you trust.
Recent AREC News
- ARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITY • GlobeNewswire Inc. • 03/12/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:04:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 03:58:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 02:15:50 PM
- First Product Incorporating Arecor’s Arestat Technology, At220, Launched in Europe • GlobeNewswire Inc. • 11/17/2023 07:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:50:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 12:35:21 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 08/28/2023 10:09:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 10:34:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 10:27:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:10:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:07:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 08:37:30 PM
- Arecor: Business Update • GlobeNewswire Inc. • 07/20/2023 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2023 08:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 12:34:01 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM